Excited to announce our oversubscribed $45M Series B to advance @mammothbiosci's next-generation CRISPR Platform into both diagnostic and therapeutic products!
A testament to the great team we're building at Mammoth and an exciting start to a busy year.https://www.bloomberg.com/news/articles/2020-01-30/heavy-weight-backed-mammoth-raises-45-million-for-crispr-r-d …
0 replies
3 proslijeđena tweeta
28 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.